Clinical Trial Update: Proof of Concept Study to Assess Safety and Efficacy of Phage Therapy in Hip or Knee Prosthetic Joint Infections Due to Staphylococcus Aureus Treated by DAIR. [Phase 2]

View source ↗

Summary

Phagenix sponsors a Phase 2 proof-of-concept trial to evaluate the safety and efficacy of bacteriophage therapy for Staphylococcus aureus hip or knee prosthetic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Prosthetic Joint Infection
• Knee Prosthetic Joint Infection

Drugs mentioned

• Bacteriophage therapy

Snippet

Sponsor: Phagenix | Conditions: Hip Prosthesis Infection, Knee Prosthesis Infection | Phase 2 | Status: NOT_YET_RECRUITING